Baxter International Inc.'s Cost-Cutting Efforts Pay Off in the Third Quarter
When Baxter International (NYSE: BAX) reported quarterly results in July, there was a stark contrast between the company's top and bottom lines. Revenue growth was essentially flat, but the medical products supplier posted strong adjusted earnings growth thanks to operational efficiencies.
Sales must grow at some point for a company to be successful, though. Baxter announced its third-quarter results before the market opened on Wednesday. This time, the company did achieve better revenue growth, but the main story once again was on Baxter's tight control of costs. Here are the highlights.
Image source: Getty Images.
Source: Fool.com
Baxter International Stock
€30.74
0.030%
Our community is currently high on Baxter International with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 48 € shows a very positive potential of 56.17% compared to the current price of 30.74 € for Baxter International.
